Real-world biologics response and super-response in the International Severe Asthma Registry cohort

- Denton, Eve, Hew, Mark, Larenas-Linnemann, Désirée, Murray, Ruth, Celis-Preciado, Carlos Andrés, Al-Lehebi, Riyad, Belhassen, Manon, Bhutani, Mohit, Bosnic-Anticevich, Sinthia Z., Bourdin, Arnaud, Brusselle, Guy G., Busby, John, Peters, Matthew J., Canonica, Giorgio Walter, Heffler, E, Chapman, KR, Charriot, J, Christoff, GC, Chung, LP, Cosio, BG, Côté, A, Costello, RW, Cushen, B, Upham, John W., Fingleton, J, Fonseca, JA, Gibson, Peter G., Heaney, LG, Huang, EW-C, Iwanaga, T, Jackson, DJ, Koh, MS, Lehtimäki, L, Máspero, J, Bulathsinhala, Lakmini, Mahboub, B, Menzies-Gow, AN, Mitchell, PD, Papadopoulos, NG, Papaioannou, AI, Perez-de-Llano, L, Perng, D-W, Pfeffer, PE, Popov, TA, Porsbjerg, CM, Tran, Trung N., Rhee, CK, Roche, N, Sadatsafavi, M, Salvi, S, Schmid, JM, Sheu, C-C, Sirena, C, Torres-Duque, CA, Salameh, L, Patel, PH, Martin, Neil, Ulrik, CS, Wang, E, Wechsler, ME, Price, DB, ISAR LUMINANT Working Group,, Bergeron, Celine, Al-Ahmad, Mona, Altraja, Alan

Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients

- Thomas, Dennis, McDonald, Vanessa M., Gillman, Andrew, Hew, Mark, Hodge, Sandra, James, Alan, Jenkins, Christine, Katelaris, Constance H., Katsoulotos, Gregory P., Langton, David, Lee, Joy, Marks, Guy, Stevens, Sean, Peters, Matthew, Radhakrishna, Naghmeh, Reynolds, Paul N., Rimmer, Janet, Sivakumaran, Pathmanathan, Upham, John W., Wark, Peter, Yang, Ian A., Gibson, Peter G., Harvey, Erin S., Baraket, Melissa, Bardin, Philip, Bowden, Jeffrey J., Bowler, Simon, Chien, Jimmy, Chung, Li Ping

Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both

- Pfeffer, Paul E., Ali, Nasloon, Altraja, Alan, Lehtimäki, Lauri, Papadopoulos, Nikolaos G., Salvi, Sundeep, Costello, Richard W., Cushen, Breda, Heffler, Enrico, Iwanaga, Takashi, Al-Ahmad, Mona, Larenas-Linnemann, Désirée, Murray, Ruth, Gibson, Peter G., Fonseca, JA, Al-Lehebi, R, Rhee, CK, Perez-de-Llano, L, Perng Steve, D-W, Mahboub, B, Wang, E, Goh, C, Lyu, J, Ulrik, Charlotte, Newell, A, Alacqua, M, Belevskiy, AS, Bhutani, M, Bjermer, L, Bjornsdottir, U, Bourdin, A, Bulow, AV, Busby, J, Canonica, GW, Tran, Trung N., Cosio, BG, Dorscheid, DR, Muñoz-Esquerre, M, FitzGerald, JM, Gil, EG, Gibson, PG, Heaney, LG, Hew, M, Hilberg, O, Hoyte, F, Maspero, Jorge, Jackson, DJ, Koh, MS, Ko, H-KB, Lee, JH, Lehmann, S, Chaves Loureiro, C, Lúðvíksdóttir, D, Menzies-Gow, AN, Mitchell, P, Papaioannou, AI, Peters, Matthew, Popov, TA, Porsbjerg, CM, Salameh, L, Sirena, C, Taillé, C, Taube, C, Tohda, Y, Wechsler, ME, Price, DB, Christoff, George C., Sadatsafavi, Mohsen, Torres-Duque, Carlos A.

An altered sputum macrophage transcriptome contributes to the neutrophilic asthma endotype

- Fricker, Michael, Qin, Ling, Chung, Kian Fan, Gibson, Peter G., Sánchez-Ovando, Stephany, Simpson, Jodie L., Baines, Katherine J., Riveros, Carlos, Scott, Hayley A., Wood, Lisa G., Wark, Peter A. B., Kermani, Nazanin Z.

Diagnosis and management of allergy and respiratory disorders in sport: an EAACI task force position paper

- Price, Oliver J., Walsted, Emil S., Rukhadze, Maia, Hull, James H., Bonini, Matteo, Brannan, John D., Bougault, Valérie, Carlsen, Kai-Håkon, Couto, Mariana, Kippelen, Pascale, Moreira, André, Pite, Helena

Impact of diet and the bacterial microbiome on the mucous barrier and immune disorders

- Alemao, Charlotte A., Budden, Kurtis F., Mann, Elizabeth R., El Omar, Emad M., Belz, Gabrielle T., Hansbro, Philip M., Gomez, Henry M., Rehman, Saima F., Marshall, Jacqueline E., Shukla, Shakti D., Donovan, Chantal, Forster, Samuel C., Yang, Ian A., Keely, Simon

Molecular markers of type 2 airway inflammation are similar between eosinophilic severe asthma and eosinophilic chronic obstructive pulmonary disease

- Fricker, Michael, McDonald, Vanessa M., Winter, Natasha A., Baines, Katherine J., Wark, Peter A. B., Simpson, Jodie L., Gibson, Peter G.

Sputum macrophage diversity and activation in asthma: Role of severity and inflammatory phenotype

- Tiotiu, Angelica, Zounemat Kermani, Nazanin, Badi, Yusef, Pavlidis, Stelios, Hansbro, Philip M., Guo, Yi-Ke, Chung, Kian Fan, Adcock, Ian M.

Sputum TNF markers are increased in neutrophilic and severe asthma and are reduced by azithromycin treatment

- Niessen, Natalie M., Gibson, Peter G., Peters, Matthew J., Marks, Guy B., Baraket, Melissaa, Simpson, Jodie L., Fricker, Michael, Baines, Katherine J., Barker, Daniel, Yang, Ian A., Upham, John W., Reynolds, Paul N., Hodge, Sandra, James, Alan L., Jenkins, Christine

Epithelial cell dysfunction, a major driver of asthma development

- Heijink, Irene H., Kuchibhotla, Virinchi N. S., Roffel, Mirjam P., Maes, Tania, Knight, Darryl A., Sayers, Ian, Nawijn, Martijn C.

Inhibition of β-catenin/CBP signalling improves airway epithelial barrier function and suppresses CCL20 release

- Kuchibhotla, Virinchi N. S., Jonker, Marnix R., de Bruin, Harold G., Noordhoek, Jacobien A., Knight, Darryl A., Nawijn, Martijn C., Heijink, Irene H.

Interaction between filaggrin mutations and neonatal cat exposure in atopic dermatitis

- Thyssen, Jacob P., Ahluwalia, Tarunveer S., Paternoster, Lavinia, Ballardini, Natalia, Bergström, Anna, Melén, Erik, Chawes, Bo L., Stokholm, Jakob, Hourihane, Jonathan O'B., O'Sullivan, Donnchadh M., Bager, Peter, Melbye, Mads, Bustamante, Mariona, Torrent, Maties, Esplugues, Ana, Duijts, Liesbeth, Hu, Chen, Elbert, Niels J., Pasmans, Suzanne G. M. A., Nijsten, Tamar E. C., Pennell, Craig E., Wang, Carol A., von berg, Andrea, Standl, Marie, Schikowski, Tamara, Herberth, Gunda, Heinrich, Joachim, Lee, Young-Ae, Marenholz, Ingo, Lau, Susanne, Curtin, John A., Simpson, Angela, Custovic, Adnan, Holt, Patrick G., Bisgaard, Hans, Bønnelykke, Klaus

Sputum basophils are increased in eosinophilic asthma compared with non-eosinophilic asthma phenotypes

- Brooks, C. R., van Dalen, C. J., Hermans, I. F., Gibson, P. G., Simpson, J. L., Douwes, J.

Targeting PP2A and proteasome activity ameliorates features of allergic airway disease in mice

- Nair, P. M., Starkey, M. R., Haw, T. J., Liu, G., Horvat, J. C., Morris, J. C., Verrills, N. M., Clark, A. R., Ammit, A. J., Hansbro, P. M.

Sex hormones and systemic inflammation are modulators of the obese-asthma phenotype

- Scott, H. A., Gibson, P. G., Garg, M. L., Upham, J. W., Wood, L. G.